Top Story

Fixed combination lowers IOP better than monotherapy

August 22, 2014

A fixed combination of brinzolamide 1% and brimonidine 0.2% was more effective than brimonidine or brinzolamide alone in lowering intraocular pressure, according to a recent study published in Ophthalmology.

Aung and colleagues conducted a randomized, multicenter, double-masked clinical trial of 560 patients with primary open-angle glaucoma or ocular hypertension over 6 months.

Perspectives on GlaucomaPerspective

Study: Brimonidine significantly reduces daytime IOP

July 25, 2014
Utilization of brimonidine in a seated position significantly lowered intraocular pressure by increasing uveoscleral outflow, according to a recent study published in…
PCON Reports

Drug-eluting contacts years away from market, researchers say

Primary Care Optometry News, July 2014
Drug-eluting contact lenses have been discussed as a potential treatment modality for decades but have yet to reach patients. To those researching and developing this…

Lack of consensus among ODs in role of combination therapies

Primary Care Optometry News, July 2014
When treating patients with glaucoma, optometrists can face many decisions on the way to achieving target intraocular pressure; among these is whether a…

Bacterial Conjunctivitis Challenge

This activity is sponsored by Sponsored by Bausch + Lomb.

10/28/2013
How much do you know about bacterial conjunctivitis treatment? Each question on this challenge features expert…
More »
CME

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

5/10/2014
Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »

Filter By:

Perspectives on Glaucoma

Fixed combination lowers IOP better than monotherapy

August 22, 2014
A fixed combination of brinzolamide 1% and brimonidine 0.2% was more effective than brimonidine or brinzolamide alone in lowering intraocular…
Perspectives on Glaucoma Perspective

Study: Brimonidine significantly reduces daytime IOP

July 25, 2014
Utilization of brimonidine in a seated position significantly lowered intraocular pressure by increasing uveoscleral outflow, according to a recent…
PCON Reports

Drug-eluting contacts years away from market, researchers say

Primary Care Optometry News, July 2014
Drug-eluting contact lenses have been discussed as a potential treatment modality for decades but have yet to reach patients. To those researching…

Lack of consensus among ODs in role of combination therapies

Primary Care Optometry News, July 2014
When treating patients with glaucoma, optometrists can face many decisions on the way to achieving target intraocular pressure; among these is…
Meeting News Coverage Video

VIDEO: Ferrucci outlines pain management in the optometric practice

June 28, 2014
Steven Ferrucci, OD, said optometrists typically manage acute pain only, treating for just a few days.
Industry News

Four studies shed light on how eye doctors can improve care for glaucoma patients

June 24, 2014
Each month, ophthalmic journals report new developments from around the world as researchers search for more effective methods of managing patients…
In the Journals

Study: Blood pressure medications linked to increased risk of AMD

June 16, 2014
In a recent Ophthalmology study, researchers found an association between vasodilator use and early age-related macular degeneration.They also found…
Industry News

Shire announces plans to submit dry eye disease NDA in early 2015

June 2, 2014
Shire plans to submit a New Drug Application to the U.S. Food and Drug Administration for lifitegrast in first-quarter 2015, according to a…
Industry News

NovaBay completes enrollment for international viral conjunctivitis trial

May 28, 2014
NovaBay Pharmaceuticals Inc. announced it has completed patient enrollment in its global phase 2b trial, BAYnovation, testing its solution to…
In the Journals

Study: Ranibizumab safe for DME patients, with stipulations

May 22, 2014
Researchers reported in a recent Retina study that treating diabetic macular edema with ranibizumab is safe when used as needed on certain…
More Headlines »